Erratum: Neuroprotective effects of gabapentin on spinal cord ischemia-reperfusion injury in rabbits. Laboratory investigation (Journal of Neurosurgery: Spine (2011) DOI: 10.3171/2011.4.SPINE10583);Neuroprotective effects of gabapentin on spinal cord ischemia-reperfusion injury in rabbits: Laboratory investigation

Journal of Neurosurgery: Spine

Volumn 15, Issue 3, 2011, Pages 228-237

  Kale, Aydemir ^a   Börcek, Alp Özgün ^a   Emmez, Hakan ^a   Yildirim, Zuhal ^a   Durdaǧ, Emre ^a   Lortlar, Neşe ^a   Kurt, Gökhan ^a   Doǧulu, Fikret ^a   Killç, Nedret ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Gabapentin; Ischemia reperfusion injury; Neuroprotection; Spinal cord injury

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; CASPASE 3; GABAPENTIN; GLUTATHIONE; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA OCCLUSION; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA; TISSUE LEVEL; TISSUE STRUCTURE; ULTRASTRUCTURE;

EID: 80052605107     PISSN: 15475654     EISSN: 15475646     Source Type: Journal    
DOI: 10.3171/2011.6.SPINE10583a     Document Type: Erratum

References (55)

1. Alderman C.J., Shah S., Foreman J.C., Chain B.M., Katz D.R.: The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic Biol Med 32:377-385, 2002 (Pubitemid 34178347)
2. Aykaç G., Uysal M., Yalçin A.S., Koçak-Toker N., Sivas A., Oz H.: The effect of chronic ethanol ingestion on hepatic lipid peroxide, glutathione, glutathione peroxidase and glutathione transferase in rats. Toxicology 36:71-76, 1985
3. Azbill R.D., Mu X., Bruce-Keller A.J., Mattson M.P., Springer J.E.: Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res 765:283-290, 1997 (Pubitemid 27397624)
4. Baptiste D.C., Fehlings M.G.: Pharmacological approaches to repair the injured spinal cord. J Neurotrauma 23:318-334, 2006 (Pubitemid 43726313)
5. Budwit-Novotny D.A., McCarty K.S., Cox E.B., Soper J.T., Mutch D.G., Creasman W.T., et al: Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 46:5419-5425, 1986 (Pubitemid 16008326)
6. Casini A.F., Ferrali M., Pompella A., Maellaro E., Comporti M.: Lipid peroxidation and cellular damage in extrahepatic tissues of bromobenzene- intoxicated mice. Am J Pathol 123:520-531, 1986 (Pubitemid 16090147)
7. Chronidou F., Apostolakis E., Papapostolou I., Grintzalis K., Georgiou C.D., Koletsis E.N., et al: Beneficial effect of the oxygen free radical scavenger amifostine (WR-2721) on spinal cord ischemia/reperfusion injury in rabbits. J Cardiothorac Surg 4:50, 2009
8. Coderre T.J., Kumar N., Lefebvre C.D., Yu J.S.: Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem 94:1131-1139, 2005 (Pubitemid 41170599)
9. Dougherty J.A., Rhoney D.H.: Gabapentin: A unique anti-epileptic agent. Neurol Res 23:821-829, 2001 (Pubitemid 33096902)
10. Dumont R.J., Okonkwo D.O., Verma S., Hurlbert R.J., Boulos P.T., Ellegala D.B., et al: Acute spinal cord injury, part I: Pathophysiologic mechanisms. Clin Neuropharmacol 24:254-264, 2001 (Pubitemid 32906712)
11. Emmez H., Börcek A.O., Kaymaz M., Kaymaz F., Durdaǧ E., Civi S., et al: Neuroprotective effects of gabapentin in experimental spinal cord injury. World Neurosurg 73:729-734, 2010
12. Erten S.F., Kocak A., Ozdemir I., Aydemir S., Colak A., Reeder B.S.: Protective effect of melatonin on experimental spinal cord ischemia. Spinal Cord 41:533-538, 2003 (Pubitemid 37260326)
13. Frenkel K.: Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol Ther 53:127-166, 1992
14. Friedlander M.A., Witko-Sarsat V., Nguyen A.T., Wu Y.C., Labrunte M., Verger C., et al: The advanced glycation endproduct pentosidine and monocyte activation in uremia. Clin Nephrol 45:379-382, 1996 (Pubitemid 26187133)
15. Gelman S.: The pathophysiology of aortic cross-clamping and unclamping. Anesthesiology 82:1026-1060, 1995
16. Gilgun-Sherki Y., Rosenbaum Z., Melamed E., Offen D.: Antioxidant therapy in acute central nervous system injury: Current state. Pharmacol Rev 54:271-284, 2002 (Pubitemid 34575717)
17. Gönenç A., Ozkan Y., Torun M., Simşek B.: Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther 26:141-144, 2001
18. Gunasekar P.G., Kanthasamy A.G., Borowitz J.L., Isom G.E.: NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: Implication for cell death. J Neurochem 65:2016-2021, 1995
19. Hall E.D.: The role of oxygen radicals in traumatic injury: Clinical implications. J Emerg Med 11 (Suppl 1):31-36, 1993
20. Hall E.D., Springer J.E.: Neuroprotection and acute spinal cord injury: A reappraisal. NeuroRx 1:80-100, 2004 (Pubitemid 46589342)
21. Harris C.C.: Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis 10:1563-1566, 1989
22. Herold J.A., Kron I.L., Langenburg S.E., Blackbourne L.H., Tribble C.G.: Complete prevention of postischemic spinal cord injury by means of regional infusion with hypothermic saline and adenosine. J Thorac Cardiovasc Surg 107:536-542, 1994 (Pubitemid 24070874)
23. Hulsebosch C.E.: Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ 26:238-255, 2002
24. Kaptanoglu E., Solaroglu I., Okutan O., Surucu H.S., Akbiyik F., Beskonakli E.: Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: Effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev 27:113-120, 2004 (Pubitemid 38374415)
25. Kim Y.K., Leem J.G., Sim J.Y., Jeong S.M., Joung K.W.: The effects of gabapentin pretreatment on brain injury induced by focal cerebral ischemia/reperfusion in the rat. Korean J Anesthesiol 58:184-190, 2010
26. Kurtel H., Granger D.N., Tso P., Grisham M.B.: Vulnerability of intestinal interstitial fluid to oxidant stress. Am J Physiol 263:G573-G578, 1992
27. Kwon B.K., Tetzlaff W., Grauer J.N., Beiner J., Vaccaro A.R.: Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 4:451-464, 2004 (Pubitemid 38992289)
28. Lang-Lazdunski L., Heurteaux C., Dupont H., Widmann C., Lazdunski M.: Prevention of ischemic spinal cord injury: Comparative effects of magnesium sulfate and riluzole. J Vasc Surg 32:179-189, 2000 (Pubitemid 30461168)
29. Lipton S.A., Rosenberg P.A.: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330:613-622, 1994
30. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J.: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
31. Mauney M.C., Blackbourne L.H., Langenburg S.E., Buchanan S.A., Kron I.L., Tribble C.G.: Prevention of spinal cord injury after repair of the thoracic or thoracoabdominal aorta. Ann Thorac Surg 59:245-252, 1995
32. McCarty K.S. Jr, Miller L.S., Cox E.B., Konrath J., McCarty K.S. Sr: Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109:716-721, 1985 (Pubitemid 16237466)
33. Miranda K.M., Espey M.G., Wink D.A.: A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62-71, 2001 (Pubitemid 34146173)
34. Oruckaptan H.H., Ozisik P., Atilla P., Tuncel M., Kilinc K., Geyik P.O., et al: Systemic administration of interleukin-10 attenuates early ischemic response following spinal cord ischemia reperfusion injury in rats. J Surg Res 155:345-356, 2009
35. Ouardouz M., Nikolaeva M.A., Coderre E., Zamponi G.W., McRory J.E., Trapp B.D., et al: Depolarization-induced Ca2+ release in ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryanodine receptors. Neuron 40: 53-63, 2003 (Pubitemid 37222463)
36. Ray G., Batra S., Shukla N.K., Deo S., Raina V., Ashok S., et al: Lipid peroxidation, free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat 59:163-170, 2000 (Pubitemid 30216139)
37. Rekling J.C.: Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation. Neurosci Lett 335:167-170, 2003
38. Rokkas C.K., Helfrich L.R. Jr, Lobner D.C., Choi D.W., Kouchoukos N.T.: Dextrorphan inhibits the release of excitatory amino acids during spinal cord ischemia. Ann Thorac Surg 58:312-320, 1994 (Pubitemid 24285095)
39. Rothstein J.D., Kuncl R.W.: Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 65:643-651, 1995
40. Salvemini D., Masini E., Anggard E., Mannaioni P.F., Vane J.: Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: Stimulation of guanylate cyclase and inhibition of platelet aggregation. Biochem Biophys Res Commun 169:596-601, 1990 (Pubitemid 20216149)
41. Sills G.J.: The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 6:108-113, 2006
42. Striano P., Striano S.: Gabapentin: A Ca2+ channel alpha 2-delta ligand far beyond epilepsy therapy. Drugs Today (Barc) 44:353-368, 2008
43. Stys P.K.: White matter injury mechanisms. Curr Mol Med 4: 113-130, 2004
44. Sun Y., Oberley L.W., Li Y.: A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497-500, 1988
45. Svensson L.G., Von Ritter C.M., Groeneveld H.T., Rickards E.S., Hunter S.J., Robinson M.F., et al: Cross-clamping of the thoracic aorta. Influence of aortic shunts, laminectomy, papaverine, calcium channel blocker, allopurinol, and superoxide dismutase on spinal cord blood flow and paraplegia in baboons. Ann Surg 204:38-47, 1986 (Pubitemid 16053823)
46. Tamir S., Tannenbaum S.R.: The role of nitric oxide (NO.) in the carcinogenic process. Biochim Biophys Acta 1288:F31-F36, 1996 (Pubitemid 26335490)
47. Taoka Y., Okajima K.: Spinal cord injury in the rat. Prog Neurobiol 56:341-358, 1998 (Pubitemid 28389723)
48. Tarlov I.M.: Acute spinal cord compression paralysis. J Neurosurg 36:10-20, 1972
49. Taskiran D., Kutay F.Z., Sozmen E., Pogun S.: Sex differences in nitrite/nitrate levels and antioxidant defense in rat brain. Neuroreport 8:881-884, 1997 (Pubitemid 27152139)
50. Taylor C.P., Gee N.S., Su T.Z., Kocsis J.D., Welty D.F., Brown J.P., et al: A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 29:233-249, 1998 (Pubitemid 28137601)
51. Tomes D.J., Agrawal S.K.: Role of Na(+)-Ca(2+) exchanger after traumatic or hypoxic/ischemic injury to spinal cord white matter. Spine J 2:35-40, 2002
52. Traa B.S., Mulholland J.D., Kadam S.D., Johnston M.V., Comi A.M.: Gabapentin neuroprotection and seizure suppression in immature mouse brain ischemia. Pediatr Res 64:81-85, 2008
53. Witko-Sarsat V., Friedlander M., Capeillère-Blandin C, Nguyen- Khoa T, Nguyen AT, Zingraff J, et al: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304-1313, 1996 (Pubitemid 26166404)
54. Xu M., Yip G.W., Gan L.T., Ng Y.K.: Distinct roles of oxidative stress and antioxidants in the nucleus dorsalis and red nucleus following spinal cord hemisection. Brain Res 1055:137-142, 2005 (Pubitemid 41224237)
55. Yoshioka T., Kawada K., Shimada T., Mori M.: Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol 135:372-376, 1979 (Pubitemid 9253643)